Ruxandra Teslo

Ruxandra Teslo, a researcher devoted to improving biopharma productivity and founder of the Common Technical Document Project, discusses the rising costs of drug development. She explains how clinical trials represent a significant bottleneck, often exacerbated by lengthy timelines and hidden inefficiencies. Ruxandra advocates for public access to regulatory submissions, suggesting that transparency can bridge the knowledge gap and spur innovation. The conversation highlights how small changes can collectively lead to major advancements in the industry.